A. Manchuelle

发表

Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.

G. Lemesle, F. Mouquet, J. Dallongeville, 2016, The New England journal of medicine.

Stent length as a potential indicator to select patients who may benefit from long- term dual antiplatelet therapy

G. Lemesle, G. Schurtz, A. Manchuelle, 2015 .

Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.

G. Lemesle, C. Bauters, E. Puymirat, 2015, Archives of cardiovascular diseases.

Accuracy of cardiac magnetic resonance imaging to rule out significant coronary artery disease in patients with systolic heart failure of unknown aetiology: Single-centre experience and comprehensive meta-analysis.

M. Remy-Jardin, M. Fertin, G. Lemesle, 2018, Archives of cardiovascular diseases.

Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study

G. Lemesle, S. Porouchani, G. Bonnet, 2021, The Lancet Regional Health - Europe.

Axillary Transcatheter Aortic Valve Replacement in Patients With Peripheral Vascular Disease.

I. Hysi, O. Fabre, A. Gommeaux, 2019, Seminars in thoracic and cardiovascular surgery.

ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France

K. Isaaz, M. Kerneis, G. Bonnet, 2021, Archives of Cardiovascular Diseases.

Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.

G. Lemesle, C. Bauters, E. Puymirat, 2015, Archives of cardiovascular diseases.

Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.

G. Lemesle, C. Bauters, E. Puymirat, 2015, Archives of Cardiovascular Diseases.